Treating Retinopathy of Prematurity in the UK
This guideline covers the screening and treatment of reinopathy of prematurity. Retinopathy of prematurity (ROP) is a potentially blinding condition affecting low gestation and very low birth weight infants. Worldwide it is a major cause of preventable blindness. Screening for ROP is undertaken to identify ROP that requires treatment. This evidence-based guideline for the treatment of ROP was developed by a guideline development group (GDG) of The Royal College of Ophthalmologists (RCOphth), the UK special interest group of ROP screeners and treaters (ROP-SIG) and the charity Bliss. The guideline was produced according to RCOphth standards for guideline development.